Hilpert, F; Greimel, E; Ottevanger, P; Rau, J; Lorusso, D; Kroep, J; Mirza, MR; Zeimet, A; Mitchell, L; Kurzeder, C.
PATIENT-REPORTED OUTCOME (PRO) RESULTS FROM THE AGO-OVAR 2.20/ENGOT-OV14/PENELOPE DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMISED PHASE III TRIAL EVALUATING CHEMOTHERAPY +/- PERTUZUMAB FOR PLATINUM-RESISTANT OVARIAN CANCER (PROC)
INT J GYNECOL CANCER. 2015; 25(9): 465-466.
Web of Science